Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
This text is a result of machine translation.
Related companies：
In-depth
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Feb 20, 2022 03:49 PM
· Healthcare
A fire broke out in a mechanical and electrical plant in Huaiyuan, Anhui Province, and local fire and public security departments are rescuing
Briefing Jan 31, 2022 10:29 AM
· Healthcare
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
Healthcare
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
See more
Read next
Insight
In-depth
Automotive · Analysis
Chinese Carmakers Expanding into Europe: Beware of Four Major Misconceptions
Apr 22, 2025 09:32 PM
Insight
In-depth
Consumer Staples · Analysis
Perfect Timing: Chagee Bridges the Cultural Gap in the U.S. Tea Market
Apr 22, 2025 03:29 PM
Insight
In-depth
Automotive · Analysis
Chinese Automakers Break into a €10 Billion Market in Europe
Apr 11, 2025 09:57 PM
Insight
In-depth
Automotive · Analysis
Tariff Escalation Through the Lens of Geopolitical Economy
Apr 11, 2025 12:32 PM